Norio Hamamatsu, PhD

President & CEO at RevolKa Ltd.

Speaker

Norio Hamamatsu is President & CEO of US office at RevolKa Ltd. Before joining RevolKa, Norio was a principal scientist at Novartis Institutes for Biomedical Research, Inc., and led multiple biologics projects of both antibody and protein therapeutics. He graduated from Kyoto University and received his Ph.D. from Saitama University, where his research focused on protein engineering and directed evolution of proteins. He reported unique methods to explore protein fitness landscapes.